F49C12.11 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
F49C12.11 antibody; Translation machinery-associated protein 7 homolog antibody; Coiled-coil domain-containing protein 72 homolog antibody
Target Names
F49C12.11
Uniprot No.

Q&A

Basic Research Questions

  • What is F49C12.11 and what is its significance in C. elegans research?

    F49C12.11 (WBGene00009880) is a C. elegans gene transcript with potential roles in multiple biological processes. Based on available research, this gene may be involved in developmental processes and stress responses in nematodes. While there isn't extensive characterization in the literature, ongoing research suggests it may serve as an important model for studying conserved biological pathways . Antibodies against F49C12.11 provide researchers with tools to study its protein expression patterns, subcellular localization, and potential functions in various tissues.

  • What expression patterns have been observed for F49C12.11 in C. elegans?

    Current research indicates F49C12.11 may be expressed in multiple tissues during C. elegans development. While comprehensive expression data is still emerging, studies suggest potential expression in germline and/or neuronal tissues. Researchers typically use transgenic reporter strains (such as GFP fusions) alongside antibody staining to validate expression patterns and determine subcellular localization in specific developmental stages .

  • How do I determine if the F49C12.11 antibody I'm using is specific?

    Validating antibody specificity is crucial for reliable research outcomes. The recommended approach includes:

    • Western blot analysis comparing wild-type and F49C12.11 knockout/knockdown worms

    • Immunostaining in both wild-type and F49C12.11 mutant strains

    • Pre-absorption tests with purified recombinant protein

    • Comparing results from different antibodies targeting different epitopes of the same protein

    These controls help distinguish specific from non-specific binding and confirm that the observed signal is truly representative of the target protein .

Advanced Research Applications

  • How can F49C12.11 antibodies be used in studies of epigenetic modification patterns?

    Recent research has emphasized the importance of epigenetic regulation in C. elegans development and response to environmental stressors. F49C12.11 antibodies can be used in ChIP (Chromatin Immunoprecipitation) experiments to identify potential binding sites and interactions with chromatin modifiers. This approach might reveal associations with histone marks like H3K9me3 and H3K27me3, which are regulated by demethylases such as jmjd-2 and jmjd-3/utx-1 in C. elegans . When designing ChIP experiments:

    • Use appropriate crosslinking conditions (typically 1-2% formaldehyde for 10-15 minutes)

    • Include input controls and IgG controls

    • Validate findings with sequential ChIP or ChIP-reChIP approaches for protein complexes

    • Follow with qPCR or sequencing to identify binding regions

  • What methodological approaches should be considered when using F49C12.11 antibodies in transgenerational studies?

    Transgenerational studies in C. elegans provide valuable insights into epigenetic inheritance. When incorporating F49C12.11 antibodies in such research:

    1. Design synchronized populations across multiple generations (F1-F3 minimum)

    2. Implement rigorous controls for each generation

    3. Consider parallel RNAi experiments to confirm antibody findings

    4. Document all environmental conditions that might affect expression

    Research suggests that environmental exposures can trigger transgenerational effects through epigenetic mechanisms in C. elegans, potentially involving genes like F49C12.11 . The experimental design should account for these variables to ensure reproducible results.

  • How can F49C12.11 antibodies be integrated into studies of protein aggregation and neurodegenerative disease models?

    C. elegans serves as an important model for studying protein aggregation in neurodegenerative diseases. F49C12.11 antibodies can be utilized to investigate potential interactions with known aggregation-prone proteins or modifiers of aggregation. Methodological considerations include:

    • Co-immunoprecipitation with aggregation-prone proteins (e.g., polyQ, Aβ, tau)

    • Proximity ligation assays to detect protein-protein interactions in situ

    • Immunofluorescence to assess colocalization with aggregates

    • Western blotting to detect shifts in solubility or post-translational modifications

    These approaches can help determine if F49C12.11 functions as an aggregation modifier or interacts with pathways involved in protein homeostasis .

  • What experimental design is needed to study F49C12.11's potential role in developmental timing?

    To investigate F49C12.11's role in developmental timing:

    1. Generate synchronized worm populations at distinct developmental stages

    2. Apply antibody staining in conjunction with stage-specific markers

    3. Perform western blots to quantify protein levels across development

    4. Combine with RNAi or CRISPR/Cas9 approaches to assess loss-of-function phenotypes

    Several C. elegans heterochronic genes regulate developmental timing through coordinated expression patterns. Determining if F49C12.11 interacts with known regulators like the BLMP-1 system could provide insights into its function .

Technical Methodology

  • What are the optimal fixation and permeabilization methods for F49C12.11 immunostaining in C. elegans?

    For successful immunostaining with F49C12.11 antibodies in C. elegans:

    Fixation MethodDurationTemperatureBest For
    4% paraformaldehyde30 minRoom tempGeneral tissue preservation
    Methanol/acetone (1:1)5 min-20°CNuclear proteins
    Bouin's solution30 minRoom tempMembrane proteins

    Follow fixation with permeabilization using 0.1-0.5% Triton X-100 in PBS for 15-30 minutes. For dense tissues like the germline, consider additional permeabilization steps such as freeze-cracking or collagenase treatment. These methods help preserve epitope accessibility while maintaining tissue morphology .

  • How do I optimize western blot protocols for detecting F49C12.11 protein?

    For optimal western blot detection of F49C12.11:

    1. Sample preparation:

      • Use RIPA buffer with protease inhibitors

      • Include phosphatase inhibitors if studying post-translational modifications

      • Sonicate briefly to ensure complete lysis

    2. Gel electrophoresis:

      • Use 10-12% polyacrylamide gels for standard separation

      • Consider gradient gels (4-20%) if molecular weight is uncertain

    3. Transfer conditions:

      • Semi-dry transfer: 15V for 30 minutes

      • Wet transfer: 100V for 1 hour or 30V overnight at 4°C

    4. Blocking and antibody incubation:

      • Block with 5% non-fat milk or BSA in TBST

      • Primary antibody dilution: start with 1:1000 and optimize

      • Incubate primary antibody overnight at 4°C

      • Secondary antibody: 1:5000-1:10000 for 1 hour at room temperature

    5. Detection:

      • Use enhanced chemiluminescence for standard detection

      • Consider fluorescent secondaries for quantitative analysis

  • What are the best methods for co-immunoprecipitation experiments using F49C12.11 antibodies?

    For effective co-immunoprecipitation (Co-IP) experiments:

    1. Prepare lysates in gentle lysis buffer (e.g., 20mM Tris-HCl pH 8.0, 137mM NaCl, 1% NP-40, 2mM EDTA) with protease inhibitors

    2. Pre-clear lysate with protein A/G beads for 1 hour at 4°C

    3. Incubate pre-cleared lysate with F49C12.11 antibody (2-5μg) overnight at 4°C

    4. Add protein A/G beads and incubate for 2-4 hours at 4°C

    5. Wash beads 4-5 times with lysis buffer

    6. Elute proteins by boiling in 2X SDS sample buffer

    7. Analyze by western blot

    Include appropriate controls:

    • IgG control antibody

    • Input sample (5-10% of starting material)

    • Reverse Co-IP if antibodies are available for suspected interacting partners

Research Applications and Integration

  • How can F49C12.11 antibodies be used in studies of germline development and reproduction?

    C. elegans germline development provides an excellent model for studying reproductive biology. F49C12.11 antibodies can be utilized to:

    1. Characterize protein expression throughout germline development using immunostaining

    2. Investigate potential roles in meiotic processes through co-localization with markers like SYP-3::GFP (synaptonemal complex protein)

    3. Assess protein dynamics during environmental stress responses that affect reproduction

    4. Study potential interactions with known germline regulators

    Research suggests genes involved in germline development may contribute to reproductive outcomes following environmental exposures . F49C12.11 antibodies can help determine if this gene participates in such processes.

  • What approaches can be used to study potential interactions between F49C12.11 and known ubiquitin-proteasome pathway components?

    To investigate F49C12.11's potential role in protein degradation pathways:

    1. Co-immunoprecipitation with E3 ubiquitin ligase components like SCFDRE-1/FBXO11

    2. Immunoblotting for ubiquitinated forms of F49C12.11 following proteasome inhibition (e.g., with MG132 treatment)

    3. Immunofluorescence co-localization with proteasome components under various stress conditions

    4. Proximity ligation assays to detect in situ interactions

    Research on BLMP-1 has demonstrated that E3 ubiquitin ligases like SCFDRE-1 regulate protein stability in C. elegans, providing a methodological framework for similar studies with F49C12.11 .

  • How can F49C12.11 antibodies be integrated into research on environmental stress responses?

    F49C12.11 may participate in stress response pathways based on similar gene studies. To investigate this:

    1. Expose worms to various stressors (oxidative stress, heat shock, environmental toxicants)

    2. Perform immunoblotting to assess changes in protein levels or post-translational modifications

    3. Use immunofluorescence to track changes in subcellular localization

    4. Combine with transcriptional reporters to correlate protein changes with gene expression

    Studies have shown that environmental exposures can trigger epigenetic changes in C. elegans that affect gene expression across generations . F49C12.11 antibodies could help determine if this protein participates in such responses.

  • What methods can be used to study potential interactions between F49C12.11 and nuclear receptors like NHR-49?

    Nuclear receptors play critical roles in C. elegans metabolism and development. To study potential F49C12.11 interactions with these factors:

    1. Co-immunoprecipitation followed by western blotting

    2. ChIP experiments to identify co-regulated genomic regions

    3. Proximity ligation assays for in situ detection of interactions

    4. Yeast two-hybrid screening as a complementary approach

    NHR-49 is involved in metabolic regulation and stress responses in C. elegans . Understanding if F49C12.11 interacts with this pathway could provide insights into its biological function.

  • How can advanced proteomics approaches be combined with F49C12.11 antibodies?

    For comprehensive proteomic analysis:

    1. Immunoprecipitation followed by mass spectrometry (IP-MS)

      • Use crosslinking approaches for transient interactions

      • Include SILAC or TMT labeling for quantitative analysis

    2. Targeted proteomics using selected reaction monitoring (SRM)

      • Develop specific peptide transitions for F49C12.11

      • Include isoform-specific peptides if applicable

    3. Proximity-dependent biotinylation (BioID or TurboID)

      • Generate fusion constructs with promiscuous biotin ligases

      • Use antibodies to validate interactions identified through biotinylation

    These approaches can identify F49C12.11 interaction networks and potential functions that might not be apparent from genetic studies alone .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.